Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Current Assets (2020 - 2025)

IceCure Medical (ICCM) has disclosed Current Assets for 5 consecutive years, with $10.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Current Assets fell 24.18% to $10.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $10.8 million, a 24.18% decrease, with the full-year FY2024 number at $10.8 million, down 24.18% from a year prior.
  • Current Assets was $10.8 million for Q4 2024 at IceCure Medical, down from $14.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $30.3 million in Q4 2021 to a low of $9.6 million in Q4 2020.
  • A 5-year average of $18.6 million and a median of $14.2 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: skyrocketed 216.22% in 2021, then plummeted 49.58% in 2023.
  • IceCure Medical's Current Assets stood at $9.6 million in 2020, then surged by 216.22% to $30.3 million in 2021, then dropped by 7.23% to $28.1 million in 2022, then tumbled by 49.58% to $14.2 million in 2023, then fell by 24.18% to $10.8 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Current Assets are $10.8 million (Q4 2024), $14.2 million (Q4 2023), and $28.1 million (Q4 2022).